Evidence suggests that renal function increasingly deteriorates in patients with apparently treatment-resistant hypertension (ATRH) in comparison with those who have non-resistant arterial hypertension (NAH). We aimed to assess the long-term decline in renal function between these patient groups and identify specific risk factors contributing to the progression of renal dysfunction. Data for 265 patients with ATRH and NAH in a hypertension excellence centre were retrospectively evaluated.
View Article and Find Full Text PDF